Form EFFECT ORAMED PHARMACEUTICALS
UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: | July 26, 2021 4:30 P.M. |
Form: | S-3 | ||||||
|
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- VTG Enhances Digital Transformation and Cloud Capabilities with Acquisition of Vana Solutions
- Fixing of coupon rates - Nykredit Realkredit A/S
- First Northwest Bancorp Reports First Quarter 2024 Financial Results
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!